EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of Five Plasma miRNAs as Biomarkers for Minimally Invasive Staging of Liver Fibrosis in β-Thalassaemia Patients

Sevgi Özkaramehmet, Savanna Andreou, Kristia Yiangou, Soteroula Christou iD, Michalis Hadjigavriel, Maria Sitarou, Katerina Pyrovolaki, Eleni Papanicolaou, Christina Flourou, Irene Savvidou iD, Panagiotis Boutsikos, Alexandra Mendoni und 3 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26199543 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sevgi Özkaramehmet und 14 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Genetics of Thalassaemia Department, The Cyprus Institute of Neurology & Genetics, 6 Iroon Avenue, Ayios Dometios, 2371 Nicosia, Cyprus. Hauptthemen laut MEDLINE: MicroRNAs, beta-Thalassemia, Liver Cirrhosis. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: TELETHON Cyprus, National Research Promotion Foundation of Cyprus, European Cooperation in Science and Technology COST Action.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Iron overload-driven liver fibrosis is a major concern in β-thalassaemia patients, but non-invasive or minimally invasive biomarkers for fibrosis staging remain limited. This study evaluated five plasma microRNAs (let-7a, miR-21, miR-29a, miR-34a, and miR-122) as potential markers for distinguishing liver fibrosis stages in β-thalassaemia. Plasma samples from 40 patients with fibrosis stages F0–F1 to F4 were analysed using RT-qPCR, normalised against the arithmetic mean of reference miRNAs miR-16 and miR-221. Expression levels of candidate miRNAs showed no statistically significant variation across stages, and logistic regression and ROC analyses revealed fair discriminatory performance for individual miRNAs and their combinations in selected stage comparisons. Notably, while for the discrimination of different fibrosis stages all five candidate miRNAs tested showed fair area-under-the-curve values between 0.7 and 0.8 individually and up to 0.917 in combination, none of these findings reached statistical significance. These results suggest that while the selected set of miRNAs reflects liver injury, its performance for precise fibrosis staging in β-thalassaemia is limited. A key cause for the low discriminatory power of these miRNAs may be the overall change of the blood miRNA transcriptome in haemoglobinopathies. The results indicate the need for validation in larger cohorts based on larger miRNA panels or the use of alternative source materials to improve diagnostic performance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsbeta-ThalassemiaLiver CirrhosisHumansBiomarkersMaleFemaleAdultYoung AdultROC CurveMiddle AgedAdolescent

Stichwörter der Autor:innen

biomarkerfibrosis stagingliver fibrosismicroRNAβ-thalassaemia

Substanzen

MicroRNAsBiomarkers

Autor:innen und Institutionen

  • Molecular Genetics of Thalassaemia Department, The Cyprus Institute of Neurology & Genetics, 6 Iroon Avenue, Ayios Dometios, 2371 Nicosia, Cyprus.
  • Biostatistics Unit, The Cyprus Institute of Neurology & Genetics, 6 Iroon Avenue, Ayios Dometios, 2371 Nicosia, Cyprus.
  • Thalassaemia Clinic Nicosia, Archbishop Makarios III Hospital, 1474 Nicosia, Cyprus.
  • Thalassaemia Clinic Limassol, Limassol General Hospital, Kato Polemidia, 4131 Limassol, Cyprus.
  • Thalassaemia Clinic Larnaca, Larnaca General Hospital, 6301 Larnaca, Cyprus.
  • Internal Medicine Department, Nicosia General Hospital, Strovolos, 2029 Nicosia, Cyprus.

ORCID-Profile: Soteroula Christou, Irene Savvidou, Marina Kleanthous, Marios Phylactides, Carsten W Lederer

Förderung

  • TELETHON Cyprus
  • National Research Promotion Foundation of Cyprus
  • European Cooperation in Science and Technology COST Action

Zitieren

APA

Özkaramehmet, S., Andreou, S., Yiangou, K., Christou, S., Hadjigavriel, M., Sitarou, M., Pyrovolaki, K., Papanicolaou, E., Flourou, C., Savvidou, I., Boutsikos, P., Mendoni, A., Kleanthous, M., Phylactides, M., & Lederer, C. W. (2025). Evaluation of Five Plasma miRNAs as Biomarkers for Minimally Invasive Staging of Liver Fibrosis in β-Thalassaemia Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199543

Vancouver

Özkaramehmet S, Andreou S, Yiangou K, Christou S, Hadjigavriel M, Sitarou M, et al. Evaluation of Five Plasma miRNAs as Biomarkers for Minimally Invasive Staging of Liver Fibrosis in β-Thalassaemia Patients. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199543

BibTeX
@article{zkaramehmet2025,
  author = {Özkaramehmet, Sevgi and Andreou, Savanna and Yiangou, Kristia and Christou, Soteroula and Hadjigavriel, Michalis and Sitarou, Maria and Pyrovolaki, Katerina and Papanicolaou, Eleni and Flourou, Christina and Savvidou, Irene and Boutsikos, Panagiotis and Mendoni, Alexandra and Kleanthous, Marina and Phylactides, Marios and Lederer, Carsten W},
  title = {Evaluation of Five Plasma miRNAs as Biomarkers for Minimally Invasive Staging of Liver Fibrosis in β-Thalassaemia Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26199543}
}
Kostenlos starten →